33 completed, 10 unknown, 7 recruiting, 7 terminated. 61 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 61 | Completed 33, Unknown 10, Recruiting 7, Terminated 7, Active not recruiting 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Bleomycin: new trials by email Literature Review of Bleomycin trials Research Report on Bleomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Biospecimen Collection, Bleomycin Sulfate, Brentuximab Vedotin - Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1875 | 2023-05-11 | 2026-11-02 |
| Brentuximab Vedotin in Early Stage Hodgkin Lymphoma Involved site radiotherapy, Doxorubicin, Bleomycin - Hodgkin Lymphoma | Phase 3 | Recruiting | University College, London | 1042 | 2022-04-14 | 2026-07-08 |
| First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) Doxorubicin, Bleomycin, Vinblastine - Hodgkin Lymphoma, Adult | Phase 3 | Recruiting | State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | 300 | 2020-02-01 | 2024-09-27 |
| FIL Study on ABVD DD-DI as Upfront Therapy in HL. Doxorubicin, Bleomycin, Vinblastine - Hodgkin Lymphoma | Phase 3 | Completed | Fondazione Italiana Linfomi - ETS | 500 | 2017-08-01 | 2025-08-08 |
| R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL Rituximab, Etoposide, Doxorubicin - Lymphoma, Large B-Cell, Diffuse | Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 402 | 2017-07-27 | 2017-07-28 |
| Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Best Practice, Biopsy Procedure, Biospecimen Collection - Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma | Phase 3 | Recruiting | Children's Oncology Group | 1780 | 2017-05-25 | 2026-08-25 |
| HD21 for Advanced Stages Bleomycin, Etoposide, Doxorubicin - Classical Hodgkin Lymphoma | Phase 3 | Unknown | University of Cologne | 1500 | 2016-07-01 | 2024-05-13 |
| TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors Paclitaxel, Carboplatin, Bleomycin - Ovarian Germ Cell Cancer, Ovarian Neoplasms | Phase 3 | Recruiting | Beihua Kong | 129 | 2015-04-01 | 2023-04-25 |
| TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors Paclitaxel, Carboplatin, Bleomycin - Ovarian Sex Cord Stromal Tumor, Ovarian Neoplasms | Phase 3 | Recruiting | Beihua Kong | 132 | 2015-04-01 | 2023-04-25 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma Bleomycin Sulfate, Brentuximab Vedotin, Cyclophosphamide - Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 600 | 2015-03-19 | 2026-10-01 |
| Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours Bleomycin (active name: Bleomycin Sulfate), Etoposide, Cisplatin - Germ Cell Tumor | Phase 3 | Recruiting | University of Sydney | 500 | 2014-02-01 | 2026-09-01 |
| Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS Etoposide (ET), Bleomycin and Vincristine (BV), Paclitaxel (PTX) - HIV-1 Infection | Phase 3 | Completed | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 334 | 2013-10-01 | 2021-10-20 |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma brentuximab vedotin, doxorubicin, bleomycin - Hodgkin Lymphoma | Phase 3 | Completed | Takeda | 1334 | 2012-11-09 | 2026-02-27 |
| GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma GA101, Rituximab, Doxorubicin - Diffuse Large B Cell Lymphoma CD20 Positive | Phase 3 | Terminated | The Lymphoma Academic Research Organisation | 671 | 2012-09-01 | 2018-03-07 |
| HD17 for Intermediate Stage Hodgkin Lymphoma BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone), ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine), 30Gy IF-RT (Involved-Field Radiotherapy) - Hodgkin Lymphoma | Phase 3 | Completed | University of Cologne | 1100 | 2012-01-13 | 2020-04-06 |
| Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma R-mabHDI and ABVD, ABVD - Hodgkin's Lymphoma | Phase 3 | Unknown | American Scitech International | 1200 | 2011-07-01 | 2011-07-20 |
| Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma bleomycin sulfate, doxorubicin hydrochloride, liposomal vincristine sulfate - Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma | Phase 3 | Completed | Children's Oncology Group | 166 | 2009-12-07 | 2022-04-28 |
| HD16 for Early Stage Hodgkin Lymphoma ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine), 20 Gy IFRT (Involved Field Radiotherapy) - Hodgkin Lymphoma | Phase 3 | Unknown | University of Cologne | 1150 | 2009-11-01 | 2020-11-04 |
| R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma Rituximab, Involved field irradiation - Hodgkin Lymphoma | Phase 3 | Terminated | Fondazione Michelangelo | 112 | 2009-09-01 | 2021-08-19 |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma | Phase 3 | Completed | University College, London | 1202 | 2008-08-29 | 2024-05-08 |
Showing 20 of 61. Sign in to see all of them.
Hodgkin Disease (24) · Lymphoma (21) · Teratoma (7) · Testicular Neoplasms (7) · Endodermal Sinus Tumor (6) · Lymphoma, Large B-Cell, Diffuse (6) · Carcinoma, Embryonal (5) · Lymphoma, Non-Hodgkin (5) · Testicular Germ Cell Tumor (5) · Acquired Immunodeficiency Syndrome (4) · HIV Infections (4) · Lymphoma, Follicular (4) · Lymphoma, Large-Cell, Immunoblastic (4) · Head and Neck Neoplasms (3) · Ovarian Germ Cell Cancer (3)
European Organisation for Research and Treatment of Cancer - EORTC (7) · Children's Oncology Group (6) · University of Cologne (6) · M.D. Anderson Cancer Center (4) · Beihua Kong (2) · Eastern Cooperative Oncology Group (2) · Fondazione Michelangelo (2) · Inovio Pharmaceuticals (2) · Medical Research Council (2) · National Cancer Institute (NCI) (2) · Sequus Pharmaceuticals (2) · University College, London (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · American Scitech International (1) · Cancer Research UK (1)
United States (27) · United Kingdom (18) · Canada (13) · Australia (10) · Belgium (9) · France (9) · Italy (9) · Puerto Rico (7) · Germany (6) · Netherlands (6) · New Zealand (6) · Poland (6) · Spain (6) · Switzerland (6) · Slovakia (5)
Volker Diehl, Prof. (3) · Alessandro M Gianni, MD (2) · Andreas Engert, Prof. (2) · Christophe Ferme (2) · H. Eghbali, MD (2) · Paul Goldfarb, MD (2) · Ralph M. Meyer, MD, FRCPC (2) · Sandra J. Horning, MD (2) · A. L Frazier (1) · AA Levine (1) · Anas Younes, MD (1) · Anna Sureda (1) · Anne Frazier, MD (1) · Antonio Pinto, MD (1) · Barry W. Hancock, MD (1)
PMID 40135712, PMID 37505794, PMID 24121121, PMID 23509310, PMID 30010775, PMID 39969278, PMID 41074963, PMID 15837968, PMID 15936157, PMID 16314615, PMID 17097834, PMID 17235042, PMID 17846017, PMID 17989384, PMID 19584400, PMID 19828373, PMID 19875337, PMID 20713848, PMID 20818855, PMID 21059637, PMID 21774708, PMID 21990399, PMID 22149921, PMID 22689804, PMID 22911615, PMID 23182987, PMID 23356491, PMID 23386127, PMID 24239220, PMID 25311218, PMID 25456363, PMID 25897153, PMID 25964643, PMID 26373676, PMID 26834240, PMID 27114593, PMID 27282998, PMID 27332902, PMID 28601705, PMID 29224502, PMID 29229324, PMID 29296710, PMID 29989855, PMID 30157803, PMID 30220622, PMID 30290903, PMID 30617130, PMID 31355926, PMID 31498753, PMID 31945149
U10CA098543 (3), U10CA180886 (3), 2004 (1), 2005 (1), 2009 (1), 2014 (1), 2023 (1), P30CA016672 (1), U01AI068636 (1), U01CA121947 (1), U10CA021115 (1), U10CA032102 (1)